167 related articles for article (PubMed ID: 167381)
1. Differences and similarities between guanosine 3',5'-cyclic monophosphate phosphodiesterase and adenosine 3',5'-cyclic monophosphate phosphodiesterase activities in neuroblastoma cells in culture.
Prasad KN; Becker G; Tripathy K
Proc Soc Exp Biol Med; 1975 Jul; 149(3):757-62. PubMed ID: 167381
[TBL] [Abstract][Full Text] [Related]
2. Role of cyclic AMP in differentiation of human neuroblastoma cells in culture.
Prasad KN; Kumar S
Cancer; 1975 Oct; 36(4):1338-43. PubMed ID: 240503
[TBL] [Abstract][Full Text] [Related]
3. Papaverine and Ro 20-1724 inhibit cyclic nucleotide phosphodiesterase activity and increase cyclic AMP levels in psoriatic epidermis in vitro.
Rusin LJ; Duell EA; Voorhees JJ
J Invest Dermatol; 1978 Aug; 71(2):154-6. PubMed ID: 210235
[TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase inhibitors: their comparative effectiveness in vitro in various organs.
Adachi K; Numano F
Jpn J Pharmacol; 1977 Feb; 27(1):97-103. PubMed ID: 194077
[TBL] [Abstract][Full Text] [Related]
5. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
Elks ML; Manganiello VC
Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
[TBL] [Abstract][Full Text] [Related]
6. Reticulol, an inhibitor of cyclic adenosine 3', 5'-monophosphate phosphodiesterase.
Furutani Y; Shimada M; Hamada M; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1975 Jul; 28(7):558-60. PubMed ID: 168174
[No Abstract] [Full Text] [Related]
7. Bovine luteal cyclic AMP and cyclic GMP phosphodiesterase activity; sensitivity to various drugs and hormones.
Goff AK; Major PW
FEBS Lett; 1976 Jan; 61(2):144-7. PubMed ID: 174943
[No Abstract] [Full Text] [Related]
8. Platelet cyclic 3':5'-nucleotide phosphodiesterase released by thrombin and calcium ionophore.
Hidaka H; Asano T
J Biol Chem; 1976 Dec; 251(23):7508-16. PubMed ID: 187590
[TBL] [Abstract][Full Text] [Related]
9. Requirements for and kinetics of growth arrest of neoplastic cells by confluent 10T1/2 fibroblasts induced by a specific inhibitor of cyclic adenosine 3':5'-phosphodiesterase.
Bertram JS; Faletto MB
Cancer Res; 1985 May; 45(5):1946-52. PubMed ID: 2985240
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibitors of specific phosphodiesterases in intact adipocytes.
Manganiello V; Degerman E; Elks M
Methods Enzymol; 1988; 159():504-20. PubMed ID: 2457789
[No Abstract] [Full Text] [Related]
11. 4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3',5'-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain.
Schwabe U; Miyake M; Ohga Y; Daly JW
Mol Pharmacol; 1976 Nov; 12(6):900-10. PubMed ID: 187926
[No Abstract] [Full Text] [Related]
12. Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
Matsumori A; Ono K; Sato Y; Shioi T; Nose Y; Sasayama S
J Mol Cell Cardiol; 1996 Dec; 28(12):2491-9. PubMed ID: 9004165
[TBL] [Abstract][Full Text] [Related]
13. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
Nemecek GM; Butcher RW
J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of two soluble adenosine cyclic 3',5'-phosphate phosphodiesterases partially purified from calf liver.
Yamamoto T; Lieberman F; Osborne JC; Manganiello VC; Vaughan M; Hidaka H
Biochemistry; 1984 Feb; 23(4):670-5. PubMed ID: 6324851
[TBL] [Abstract][Full Text] [Related]
15. Effect of sodium butyrate in combination with prostaglandin E1 and inhibitors of cyclic nucleotide phosphodiesterase on human amelanotic melanoma cells in culture.
Prasad KN; Sakamoto A
Experientia; 1978 Dec; 34(12):1575-6. PubMed ID: 215447
[TBL] [Abstract][Full Text] [Related]
16. Partial purification of adenosine 3',5'-cyclic monophosphate phosphodiesterases from rat pancreas in the presence of excess protease inhibitors.
Terai M; Furihata C; Matsushima T; Sugimura T
Arch Biochem Biophys; 1976 Oct; 176(2):621-9. PubMed ID: 185966
[No Abstract] [Full Text] [Related]
17. Cyclic nucleotide hydrolysis in the thyroid gland. General properties and key role in the interrelations between concentrations of adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate.
Erneux C; Van Sande J; Dumont JE; Boeynaems JM
Eur J Biochem; 1977 Jan; 72(1):137-47. PubMed ID: 12974
[TBL] [Abstract][Full Text] [Related]
18. Cyclic AMP phosphodiesterase activity in fetal and adult muscle of the rhesus monkey.
Bocek RM; Beatty CH
Dev Biol; 1976 Feb; 48(2):382-91. PubMed ID: 176071
[No Abstract] [Full Text] [Related]
19. Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. IV. An evaluation of a role for cyclic adenosine monophosphate.
Cubeddu L; Barnes E; Weiner N
J Pharmacol Exp Ther; 1975 Apr; 193(1):105-27. PubMed ID: 166157
[TBL] [Abstract][Full Text] [Related]
20. Croton oil- and benzo(a)pyrene-induced changes in cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate phosphodiesterase activities in mouse epidermis.
Verma AK; Froscio M; Murray AW
Cancer Res; 1976 Jan; 36(1):81-7. PubMed ID: 174815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
